DecisionDx-Melanoma Gene Expression Profile Test in Stage III Cutaneous Melanoma Patients with Complete Lymph Node Dissection

Project: Research project

Project Details

StatusActive
Effective start/end date3/8/193/8/22

Funding

  • Castle Biosciences, Inc. (Prot #STU00207743)